TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
OABI

OmniAb Inc.

Healthcare · Biotechnology

4.50$ +0.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement OABI
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
43.1% 27.5% 57.1% 74.6% 118.2%
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% -18.2%
72.1% 106.6% 112.9% 81.9% 165.5% 208.8% 255.8%
47.2% 43.9% 48.8% 42.2% 97.5% 116.5% 156.5%
171.1% 210.1% 202.5% 145.1% 303.2% 382.3% 365.0%
-71.1% -110.1% -102.5% -45.1% -203.2% -282.3% -383.1%
0.0% 0.0% 0.0% 1.0%
-71.1% -102.0% -98.9% -44.1% -188.4% -270.6% -355.2%
3.1% -26.5% -21.0% -6.3% -40.2% -35.5% -8.1%
-74.2% -75.5% -77.8% -37.8% -148.2% -235.1% -347.0%
-17.8% -47.0% -52.1% -13.2% -131.3% -181.2% -238.6%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?